| UniProt ID | PEDF_HUMAN | |
|---|---|---|
| UniProt AC | P36955 | |
| Protein Name | Pigment epithelium-derived factor | |
| Gene Name | SERPINF1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 418 | |
| Subcellular Localization | Secreted . Melanosome . Enriched in stage I melanosomes. | |
| Protein Description | Neurotrophic protein; induces extensive neuronal differentiation in retinoblastoma cells. Potent inhibitor of angiogenesis. As it does not undergo the S (stressed) to R (relaxed) conformational transition characteristic of active serpins, it exhibits no serine protease inhibitory activity.. | |
| Protein Sequence | MQALVLLLCIGALLGHSSCQNPASPPEEGSPDPDSTGALVEEEDPFFKVPVNKLAAAVSNFGYDLYRVRSSTSPTTNVLLSPLSVATALSALSLGAEQRTESIIHRALYYDLISSPDIHGTYKELLDTVTAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGNPRLDLQEINNWVQAQMKGKLARSTKEIPDEISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGSMSIIFFLPLKVTQNLTLIEESLTSEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFDSPDFSKITGKPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPRGP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 20 | Pyrrolidone_carboxylic_acid | LLGHSSCQNPASPPE HHCCCCCCCCCCCCC | 61.97 | - | |
| 20 | Pyrrolidone_carboxylic_acid | LLGHSSCQNPASPPE HHCCCCCCCCCCCCC | 61.97 | 12737624 | |
| 20 | Pyrrolidone_carboxylic_acid | LLGHSSCQNPASPPE HHCCCCCCCCCCCCC | 61.97 | 12737624 | |
| 24 | Phosphorylation | SSCQNPASPPEEGSP CCCCCCCCCCCCCCC | 42.09 | 26657352 | |
| 24 | O-linked_Glycosylation | SSCQNPASPPEEGSP CCCCCCCCCCCCCCC | 42.09 | OGP | |
| 30 | O-linked_Glycosylation | ASPPEEGSPDPDSTG CCCCCCCCCCCCCCC | 29.43 | OGP | |
| 30 | Phosphorylation | ASPPEEGSPDPDSTG CCCCCCCCCCCCCCC | 29.43 | 26657352 | |
| 35 | Phosphorylation | EGSPDPDSTGALVEE CCCCCCCCCCCCCCC | 33.84 | 26657352 | |
| 36 | O-linked_Glycosylation | GSPDPDSTGALVEEE CCCCCCCCCCCCCCC | 33.58 | OGP | |
| 36 | Phosphorylation | GSPDPDSTGALVEEE CCCCCCCCCCCCCCC | 33.58 | 26657352 | |
| 114 | Phosphorylation | ALYYDLISSPDIHGT HHHHHHHCCCCCCCC | 43.02 | 22817900 | |
| 152 | Phosphorylation | EKKLRIKSSFVAPLE EEEHHCCEEEEECCH | 27.00 | - | |
| 153 | Phosphorylation | KKLRIKSSFVAPLEK EEHHCCEEEEECCHH | 20.81 | - | |
| 227 | Phosphorylation | KFDSRKTSLEDFYLD CCCCCCCCHHHHCCC | 32.56 | 21082442 | |
| 283 | Phosphorylation | FFLPLKVTQNLTLIE EEEEEEECCCEEHHH | 15.34 | - | |
| 285 | N-linked_Glycosylation | LPLKVTQNLTLIEES EEEEECCCEEHHHHH | 26.15 | 11562499 | |
| 285 | N-linked_Glycosylation | LPLKVTQNLTLIEES EEEEECCCEEHHHHH | 26.15 | 11562499 | |
| 287 | Phosphorylation | LKVTQNLTLIEESLT EEECCCEEHHHHHHH | 32.99 | - | |
| 294 | Phosphorylation | TLIEESLTSEFIHDI EHHHHHHHHHHHHHH | 35.17 | - | |
| 295 | Phosphorylation | LIEESLTSEFIHDID HHHHHHHHHHHHHHH | 35.48 | - | |
| 313 | Phosphorylation | KTVQAVLTVPKLKLS CHHHHHEECCCCCCE | 28.32 | 24719451 | |
| 316 | Methylation | QAVLTVPKLKLSYEG HHHEECCCCCCEECC | 54.65 | - | |
| 372 | O-linked_Glycosylation | NEDGAGTTPSPGLQP CCCCCCCCCCCCCCC | 22.35 | OGP | |
| 374 | O-linked_Glycosylation | DGAGTTPSPGLQPAH CCCCCCCCCCCCCCE | 29.52 | OGP |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 24 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 24 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
| 24 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| 114 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 114 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
| 114 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| 227 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 227 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 227 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PEDF_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PEDF_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PLPL2_HUMAN | PNPLA2 | physical | 18191271 | |
| EPMIP_HUMAN | EPM2AIP1 | physical | 25416956 | |
| LMBL2_HUMAN | L3MBTL2 | physical | 28514442 | |
| KLHL8_HUMAN | KLHL8 | physical | 28514442 | |
| TBA4A_HUMAN | TUBA4A | physical | 28514442 | |
| GRP78_HUMAN | HSPA5 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 613982 | Osteogenesis imperfecta 6 (OI6) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Crystal structure of human PEDF, a potent anti-angiogenic and neuritegrowth-promoting factor."; Simonovic M., Gettins P.G.W., Volz K.; Proc. Natl. Acad. Sci. U.S.A. 98:11131-11135(2001). Cited for: X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 21-418, AND GLYCOSYLATION ATASN-285. | |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-285, AND MASSSPECTROMETRY. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-285, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Extracellular phosphorylation converts pigment epithelium-derivedfactor from a neurotrophic to an antiangiogenic factor."; Maik-Rachline G., Shaltiel S., Seger R.; Blood 105:670-678(2005). Cited for: PHOSPHORYLATION AT SER-24; SER-114 AND SER-227. | |